Res. Asst. PhD MERVE AKKULAK

Publication Network

Articles 6

1. Modulation of Caco-2 Colon Cancer Cell Viability and CYP2W1 Gene Expression by Hesperidin-treated Lacticaseibacillus rhamnosus GG (LGG) Cell-free Supernatants.

Akkulak M., Evin E., Durukan O., Celebioglu H. U., Adali O.

Anti-cancer agents in medicinal chemistry , vol.24, pp.372-378, 2024 (SCI-Expanded, Scopus)

2. Xenogenic Neural Stem Cell-Derived Extracellular Nanovesicles Modulate Human Mesenchymal Stem Cell Fate and Reconstruct Metabolomic Structure

DERKUŞ B., Isik M., Eylem C. C., ERGİN İ., Camci C. B., Bilgin S., et al.

ADVANCED BIOLOGY , vol.6, no.6, 2022 (SCI-Expanded)

3. Association of cholesterol 7α-hydroxylase (CYP7A1) promoter polymorphism (rs3808607) and cholesterol 24S-hydroxylase (CYP46A1) intron 2 polymorphism (rs754203) with serum lipids, vitamin D levels, and multiple sclerosis risk in the Turkish population

SEZER E., CAN DEMİRDÖĞEN B., Demirkaya S., Bulut G., AKKULAK M., EVİN E., et al.

Neurological Sciences , vol.43, no.4, pp.2611-2620, 2022 (SCI-Expanded, Scopus)

4. Effect of cisplatin treatment on protein expression of vitamin D metabolizing CYP24A1 in PC3 cell line

EVİN E., Durukan O., AKKULAK M., ADALI O.

FEBS OPEN BIO , vol.8, pp.326, 2018 (SCI-Expanded, Scopus)

5. Effect of quercetin on mRNA and protein expressions of vitamin D metabolizing CYP27B1 and CYP24A1 in human embryonic kidney cell line (HEK-293)

Akkulak M., Evin E., Durukan Ö., Özhan G., Adalı O.

FEBS OPEN BIO , vol.8, pp.352, 2018 (SCI-Expanded, Scopus)

6. Alteration of protein and gene expressions of Hexokinase II in PC3 cell lines by cisplatinmetformin combination treatment

Durukan Ö., Akkulak M., Evin E., Arslan Ş., Adalı O.

FEBS OPEN BIO , vol.8, pp.352, 2018 (SCI-Expanded, Scopus) Sustainable Development

Papers Presented at Peer-Reviewed Scientific Conferences 9

1. Angiogenic potential of CYP2W1 gene in tumorigenesis

Akkulak M., Adalı O., Durukan Ö.

FEBS2023, Tours, France, 8 - 12 July 2023, pp.74, (Summary Text)

2. Angiogenic Potential of CYP2W1 Gene in Tumorigenesis

Akkulak M., Adalı O., Durukan Ö.

FEBS2023, Tours, France, 8 - 12 July 2023, pp.74, (Summary Text)

3. EFFECT OF ONCOFETAL CYP2W1 GENE ON EPITHELIAL-MESENCHYMAL TRANSITION MARKERS

Akkulak M., Durukan Ö., Evin E., Adalı O.

International Biochemistry Congreess 2022, İzmir, Turkey, 26 - 30 October 2022, vol.50, no.49, pp.136-137, (Summary Text)

4. Investigating the role of CYP4X1 gene during brain tumor angiogenesis via RNAi mediated gene repression

Durukan Ö., Akkulak M., Evin E., Adalı O.

TBS International Biochemistry Congress 2022 - 33th National Biochemistry Congress, İzmir, Turkey, 26 - 30 October 2022, vol.50, no.50, pp.137, (Summary Text)

5. Analysis of Protein and mRNA Expressions of CYP1A1 and CYP2E1 Enzymes In Liver, Colon And Prostate Cancer Cell Lines to Study Drug and Carcinogen Metabolism

Evin E., Karakurt S., Akkulak M., Adalı O.

International Congress on Advances in BioScience and Biotechnology, Sarajevo, Bosnia And Herzegovina, 25 - 29 October 2017, pp.59, (Summary Text) Sustainable Development

6. Effect of resveratrol on mRNA and protein expressions of Vitamin D metabolizing CYP24A1 in human embryonic kidney cell line (HEK-293)

AKKULAK M., EVİN E., DURUKAN Ö., ÖZHAN H. G., ADALI O.

10th International Symposium on Health Informatics and Bioinformatics (HIBIT 2017), 28 - 30 June 2017, (Summary Text)